ClearPoint Neuro (CLPT) Projected to Post Quarterly Earnings on Tuesday

Posted by MarketBeat News on May 11th, 2025

ClearPoint Neuro (NASDAQ:CLPT – Get Free Report) is projected to issue its Q1 2025 quarterly earnings data after the market closes on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $8.21 million for the quarter. ClearPoint Neuro has set its FY 2025 guidance at EPS.

ClearPoint Neuro (NASDAQ:CLPT – Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.05). ClearPoint Neuro had a negative return on equity of 62.10% and a negative net margin of 59.64%. The business had revenue of $7.77 million for the quarter, compared to analysts’ expectations of $8.23 million. On average, analysts expect ClearPoint Neuro to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ClearPoint Neuro Stock Performance

ClearPoint Neuro stock opened at $14.18 on Friday. ClearPoint Neuro has a 1 year low of $5.11 and a 1 year high of $19.22. The firm has a 50 day moving average price of $12.85 and a 200 day moving average price of $14.21. The company has a market cap of $396.76 million, a price-to-earnings ratio of -20.55 and a beta of 1.03.

Analysts Set New Price Targets

Want More Great Investing Ideas?

A number of research analysts recently weighed in on the company. B. Riley lifted their target price on ClearPoint Neuro from $15.00 to $20.00 and gave the company a “buy” rating in a report on Tuesday, January 28th. Lake Street Capital boosted their price target on ClearPoint Neuro from $17.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, January 21st. Finally, Stifel Nicolaus lifted their target price on ClearPoint Neuro from $19.00 to $25.00 and gave the stock a “buy” rating in a research report on Tuesday, April 1st.

View Our Latest Report on CLPT

ClearPoint Neuro Company Profile

(Get Free Report)

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.